Cannabis Industry 23 November 2025 - 9 January 2026

Tilray shares jumped nearly 9% to $9.95 in premarket trading after reporting fiscal Q2 revenue of $217.5 million and a narrowed net loss of $43.5 million. The company reaffirmed its full-year adjusted profit target and said it moved to a net cash position. Gross margin slipped, and craft beer sales remained under pressure. Traders are watching if the gains hold at the open.

Tilray Brands shares traded near $10.53 on December 24, 2025, following sharp gains in the second half of the year. President Donald Trump signed an executive order on December 18 to begin the process of reclassifying marijuana from Schedule I to Schedule III. The move sparked volatility across cannabis stocks, with prices swinging as investors weighed the potential impact. The order does not legalize cannabis but directs federal agencies to review its status.

Tilray Brands (TLRY) soared 44% to $12.15 on Dec. 12, with trading volume reaching 81.58 million shares after reports that Donald Trump may push to loosen federal marijuana restrictions. Shares gained nearly 69% for the week. After hours, TLRY traded as high as $13.14. The White House said no final decision has been made on marijuana rescheduling.